학술논문
The clinically relevant CHK1 inhibitor MK-8776 induces the degradation of the oncogenic protein PML-RARα and overcomes ATRA resistance in acute promyelocytic leukemia cells
Document Type
Article
Author
Source
In: Biochemical Pharmacology . (Biochemical Pharmacology, August 2023, 214)
Subject
Language
English
ISSN
18732968
00062952
00062952